Tesileanu, C. M. S., van den Bent, M. J., Sanson, M., Wick, W., Brandes, A. A., Clement, P. M., Erridge, S. C., Vogelbaum, M. A., Nowak, A. K., Baurain, J. F., Mason, W. P., Wheeler, H., Chinot, O. L., Gill, S., Griffin, M., Rogers, L., Taal, W., Rudà, R., Weller, M., McBain, C., van Linde, M. E., Sabedot, T. S., Hoogstrate, Y., von Deimling, A., de Heer, I., van IJcken, W. F. J., Brouwer, R. W. W., Aldape, K., Jenkins, R. B., Dubbink, H. J., Kros, J. M., Wesseling, P., Cheung, K. J., Golfinopoulos, V., Baumert, B. G., Gorlia, T., Noushmehr, H., & French, P. J. (2021). prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. Neuro-oncology, 23(9), 1547–1559. http://access.bl.uk/ark:/81055/vdc_100139923183.0x000012